Trial
NCT00625079
Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of California, Los Angeles
Collaborators
Pfizer
Condition
Pulmonary Arterial Hypertension
Intervention
sildenafil
Why stopped
inclusion/exclusion criteria limited enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-01